XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Capital Stock
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Capital Stock

(14) CAPITAL STOCK

We have authorized capital stock of 485.0 million shares which includes 475.0 million shares of common stock and 10.0 million shares of preferred stock. We currently have no preferred stock issued or outstanding. The following is a schedule of changes in the number of common shares outstanding since the beginning of 2022:

 

 

 

Nine Months Ended
September 30,
2023

 

 

Year Ended
December 31,
2022

 

Beginning balance

 

 

238,885,730

 

 

 

249,792,908

 

Restricted stock grants

 

 

50,238

 

 

 

671,303

 

Restricted stock units vested

 

 

1,754,923

 

 

 

1,827,625

 

Performance stock units issued

 

 

1,057,245

 

 

 

590,940

 

Performance stock dividends

 

 

6,276

 

 

 

1,843

 

Treasury shares

 

 

(399,530

)

 

 

(13,998,889

)

Ending balance

 

 

241,354,882

 

 

 

238,885,730

 

 

 

Stock Repurchase Program

In 2019, the board of directors approved a stock repurchase program which was increased in size in 2022. At September 30, 2023, we had a remaining authorization to repurchase up to approximately $1.1 billion of our common stock. Under this program, we may repurchase shares in open market transactions, from time to time, in accordance with applicable SEC rules and federal securities laws. Purchases under the program are made at our discretion and may change based upon market conditions. In first nine months 2023, we repurchased 400,000 shares at an aggregate cost of $9.7 million. The following is a schedule of the change in treasury shares for the three and nine months ended September 30, 2023:

 

 

 

Three Months Ended
September 30,
2023

 

 

Nine Months Ended
September 30,
2023

 

Beginning balance

 

 

24,401,065

 

 

 

24,001,535

 

Rabbi trust shares distributed/sold

 

 

 

 

 

(470

)

Shares repurchased

 

 

 

 

 

400,000

 

Ending balance

 

 

24,401,065

 

 

 

24,401,065